Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1625428

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1625428

Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type, Application, and Region - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

Description

Table of Contents

List of Tables

The global opioid market size is expected to reach USD 28.45 billion by 2034, according to a new study by Polaris Market Research. The report "Opioid Market Size, Share, Trends, Industry Analysis Report: By Class, Product, Release Type (Immediate-Release/Short-Acting Opioid and Extended-Release/Long-Acting Opioid), Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The opioid market growth is attributed to an increase in partnerships between companies. Collaborations between pharmaceutical firms, healthcare providers, and research institutions are facilitating the development of new formulations and improved delivery systems for opioid therapies. These alliances enable organizations to combine resources, leverage expertise, and expedite the research and development process, allowing for faster introduction of effective pain management solutions to the market. Additionally, strategic partnerships improve distribution networks and expand access to opioid medications, particularly in underserved areas. Companies join forces to address challenges related to opioid prescribing such as safety concerns and regulatory compliance; they are promoting a more holistic approach to pain management, ultimately strengthening the presence of opioids in the market.

The rising prevalence of traumatic injuries significantly drives opioid market demand due to the need for effective pain management. The US reports around 1.5 million traumatic brain injury cases annually, with many requiring hospitalization and long-term pain management. The CDC highlights that pain management is essential for recovery in these cases, increasing the demand for opioids. Additionally, heightened awareness of the long-term effects of TBIs emphasizes the necessity for comprehensive pain strategies, further leading to an expected rise in opioid prescriptions. Consequently, the opioid market size is poised for growth in the projected years.

The opioid market is expanding due to increased awareness and education about pain management. Both patients and healthcare providers are learning more about the different treatment options available. In the United States, nearly 50 million adults suffer from chronic pain. Updated medical guidelines are helping doctors feel more confident when prescribing opioids, ensuring they are used properly to manage pain. This growing understanding of pain treatment options is contributing to the rise in the use of opioids for managing chronic pain.

Opioid Market Report Highlights

By release type, the extended-release/long-acting opioid segment is anticipated to experience substantial growth at a significant CAGR in the global market during the forecast period. This growth is attributed to an increase in the prevalence of extended pain and traumatic injuries requiring long-acting opioids.

The pain management segment, by application, accounted for the largest revenue share of the market in 2024 due to the rising number of chronic and acute injuries.

In 2024, North America dominated the global opioid market share due to the increasing number hospitals, leading to the increase in prescription rate.

The opioid market in India is projected for substantial growth due to the increasing funding and foreign direct investment inflow.

A few global key market players are Aurobindo Pharma Limited; Assertio Therapeutics, Inc.; AbbVie Inc.; Actavis Plc.; Amneal Pharmaceuticals LLC; Boehringer Ingelheim International GmbH; Cadila Healthcare Limited; Fresenius Kabi; Mallinckrodt Pharmaceuticals; Endo International plc; Johnson & Johnson Corporation; Lupin Limited; Nesher Pharmaceuticals LLC; Purdue Pharma L.P.; Pfizer Inc.; Rhodes Pharmaceuticals L.P.; Sun Pharmaceutical Industries Limited; Trevena Inc.; Teva Pharmaceutical Industries Ltd.

Polaris Market Research has segmented the opioid market report on the basis of class, product, release type, application, and region:

By Class Outlook (Revenue - USD Billion, 2020-2034)

  • § Natural
  • § Semi-Synthetic
  • § Fully Synthetic

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • § Codeine
  • § Fentanyl
  • § Oxycodone
  • § Methadone
  • § Morphine
  • § Hydrocodone
  • § Tramadol
  • § Propoxyphene
  • § Others

By Release Type Outlook (Revenue - USD Billion, 2020-2034)

  • § Immediate-Release/Short-Acting Opioid
  • § Extended-Release/Long-Acting Opioid
  • By Application (Revenue - USD Billion, 2020-2034)
  • § Pain Management
  • § Neuropathic
  • § Migraine
  • § Orthopedic and Musculoskeletal
  • § Arthritis
  • § Fibromyalgia
  • § Others
  • § Cancer Pain
  • § Brain
  • § Breast
  • § Colorectal
  • § Blood
  • § Skin
  • § Prostate
  • § Others
  • § Cough Treatment
  • § Analgesia
  • § Diarrhea Treatment
  • § De-addiction
  • § Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa
Show more
Product Code: PM1368

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Opioid Market Insights

  • 4.1. Opioid Market - Market Snapshot
  • 4.2. Opioid Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Traumatic Injuries is Driving the Market Size
      • 4.2.1.2. Increasing Investment for Expansion of Medical Infrastructure Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent Government Regulation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Opioid Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Opioid Market, by Class

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Opioid Market, by Class, 2020-2034 (USD billion)
  • 5.3. Natural
    • 5.3.1. Global Opioid Market, by Natural, by Region, 2020-2034 (USD billion)
  • 5.4. Semi-synthetic
    • 5.4.1. Global Opioid Market, by Semi-synthetic, by Region, 2020-2034 (USD billion)
  • 5.5. Fully synthetic
    • 5.5.1. Global Opioid Market, by Fully synthetic, by Region, 2020-2034 (USD billion)

6. Global Opioid Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Opioid Market, by Product, 2020-2034 (USD billion)
  • 6.3. Codeine
    • 6.3.1. Global Opioid Market, by Codeine, by Region, 2020-2034 (USD billion)
  • 6.4. Fentanyl
    • 6.4.1. Global Opioid Market, by Fentanyl, by Region, 2020-2034 (USD billion)
  • 6.5. Oxycodone
    • 6.5.1. Global Opioid Market, by Oxycodone, by Region, 2020-2034 (USD billion)
  • 6.6. Methadone
    • 6.6.1. Global Opioid Market, by Methadone, by Region, 2020-2034 (USD billion)
  • 6.7. Morphine
    • 6.7.1. Global Opioid Market, by Morphine, by Region, 2020-2034 (USD billion)
  • 6.8. Hydrocodone
    • 6.8.1. Global Opioid Market, by Hydrocodone, by Region, 2020-2034 (USD billion)
  • 6.9. Tramadol
    • 6.9.1. Global Opioid Market, by Tramadol, by Region, 2020-2034 (USD billion)
  • 6.10. Propoxyphene
    • 6.10.1. Global Opioid Market, by Propoxyphene, by Region, 2020-2034 (USD billion)
  • 6.11. Others
    • 6.11.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)

7. Global Opioid Market, by Release Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Opioid Market, by Release Type, 2020-2034 (USD billion)
  • 7.3. Immediate-release/Short-acting opioid
    • 7.3.1. Global Opioid Market, by Immediate-release/Short-acting opioid by Region, 2020-2034 (USD billion)
  • 7.4. Extended-release/Long-acting opioid
    • 7.4.1. Global Opioid Market, by Extended-release/Long-acting opioid, by Region, 2020-2034 (USD billion)

8. Global Opioid Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Opioid Market, by Application, 2020-2034 (USD billion)
  • 8.3. Pain Management
    • 8.3.1. Global Opioid Market, by Pain Management, by Region, 2020-2034 (USD billion)
    • 8.3.2. Neuropathic
      • 8.3.2.1. Global Opioid Market, by Neuropathic, by Region, 2020-2034 (USD billion)
    • 8.3.3. Migraine
      • 8.3.3.1. Global Opioid Market, by Migraine, by Region, 2020-2034 (USD billion)
    • 8.3.4. Orthopedic and Musculoskeletal
      • 8.3.4.1. Global Opioid Market, by Orthopedic and Musculoskeletal, by Region, 2020-2034 (USD billion)
    • 8.3.5. Arthritis
      • 8.3.5.1. Global Opioid Market, by Arthritis, by Region, 2020-2034 (USD billion)
    • 8.3.6. Fibromyalgia
      • 8.3.6.1. Global Opioid Market, by Fibromyalgia, by Region, 2020-2034 (USD billion)
    • 8.3.7. Others
      • 8.3.7.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)
  • 8.4. Cancer Pain
    • 8.4.1. Global Opioid Market, by Cancer Pain, by Region, 2020-2034 (USD billion)
    • 8.4.2. Brain
      • 8.4.2.1. Global Opioid Market, by Brain, by Region, 2020-2034 (USD billion)
    • 8.4.3. Breast
      • 8.4.3.1. Global Opioid Market, by Breast, by Region, 2020-2034 (USD billion)
    • 8.4.4. Colorectal
      • 8.4.4.1. Global Opioid Market, by Colorectal, by Region, 2020-2034 (USD billion)
    • 8.4.5. Blood
      • 8.4.5.1. Global Opioid Market, by Blood, by Region, 2020-2034 (USD billion)
    • 8.4.6. Skin
      • 8.4.6.1. Global Opioid Market, by Skin, by Region, 2020-2034 (USD billion)
    • 8.4.7. Prostate
      • 8.4.7.1. Global Opioid Market, by Prostate, by Region, 2020-2034 (USD billion)
    • 8.4.8. Others
      • 8.4.8.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)
  • 8.5. Cough treatment
    • 8.5.1. Global Opioid Market, by Cough treatment, by Region, 2020-2034 (USD billion)
  • 8.6. Analgesia
    • 8.6.1. Global Opioid Market, by Analgesia, by Region, 2020-2034 (USD billion)
  • 8.7. Diarrhea treatment
    • 8.7.1. Global Opioid Market, by Diarrhea treatment, by Region, 2020-2034 (USD billion)
  • 8.8. De-addiction
    • 8.8.1. Global Opioid Market, by De-addiction, by Region, 2020-2034 (USD billion)
  • 8.9. Others
    • 8.9.1. Global Opioid Market, by Others, by Region, 2020-2034 (USD billion)

9. Global Opioid Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Opioid Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Opioid Market - North America
    • 9.3.1. North America: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.3.2. North America: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.3.3. North America: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.3.4. North America: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.3.5. Opioid Market - U.S.
      • 9.3.5.1. U.S.: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.3.5.2. U.S.: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.3.5.3. U.S.: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.3.5.4. U.S.: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.3.6. Opioid Market - Canada
      • 9.3.6.1. Canada: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.4. Opioid Market - Europe
    • 9.4.1. Europe: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.4.2. Europe: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.4.3. Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.4.4. Europe: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.5. Opioid Market - UK
      • 9.4.5.1. UK: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.6. Opioid Market - France
      • 9.4.6.1. France: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.6.2. France: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.6.3. France: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.6.4. France: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.7. Opioid Market - Germany
      • 9.4.7.1. Germany: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.8. Opioid Market - Italy
      • 9.4.8.1. Italy: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.9. Opioid Market - Spain
      • 9.4.9.1. Spain: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.10. Opioid Market - Netherlands
      • 9.4.10.1. Netherlands: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.11. Opioid Market - Russia
      • 9.4.11.1. Russia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.4.12. Opioid Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.5. Opioid Market - Asia Pacific
    • 9.5.1. Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.5. Opioid Market - China
      • 9.5.5.1. China: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.5.2. China: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.5.3. China: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.5.4. China: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.6. Opioid Market - India
      • 9.5.6.1. India: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.6.2. India: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.6.3. India: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.6.4. India: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.7. Opioid Market - Malaysia
      • 9.5.7.1. Malaysia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.8. Opioid Market - Japan
      • 9.5.8.1. Japan: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.9. Opioid Market - Indonesia
      • 9.5.9.1. Indonesia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.10. Opioid Market - South Korea
      • 9.5.10.1. South Korea: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.11. Opioid Market - Australia
      • 9.5.11.1. Australia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.5.12. Opioid Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.6. Opioid Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.5. Opioid Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.6. Opioid Market - UAE
      • 9.6.6.1. UAE: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.7. Opioid Market - Israel
      • 9.6.7.1. Israel: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.8. Opioid Market - South Africa
      • 9.6.8.1. South Africa: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.6.9. Opioid Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)
  • 9.7. Opioid Market - Latin America
    • 9.7.1. Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.5. Opioid Market - Mexico
      • 9.7.5.1. Mexico: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.6. Opioid Market - Brazil
      • 9.7.6.1. Brazil: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.7. Opioid Market - Argentina
      • 9.7.7.1. Argentina: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Opioid Market, by Application, 2020-2034 (USD billion)
    • 9.7.8. Opioid Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Opioid Market, by Class, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Opioid Market, by Product, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Aurobindo Pharma Limited
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Assertio Therapeutics, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. AbbVie Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Actavis Plc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Amneal Pharmaceuticals LLC
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Boehringer Ingelheim International GmbH
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Cadila Healthcare Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Fresenius Kabi
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Mallinckrodt Pharmaceuticals
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Endo International plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Johnson & Johnson Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lupin Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Nesher Pharmaceuticals LLC
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Purdue Pharma L.P.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Pfizer Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Rhodes Pharmaceuticals L.P.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Sun Pharmaceutical Industries Limited
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Trevena Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Teva Pharmaceutical Industries Ltd.
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development
Show more
Product Code: PM1368

List of Tables:

Table 1 Global Opioid Market, by Class, 2020-2034 (USD billion)

Table 2 Global Opioid Market, by Product, 2020-2034 (USD billion)

Table 3 Global Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 4 Global Opioid Market, by Application, 2020-2034 (USD billion)

Table 5 North America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 6 North America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 7 North America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 8 North America: Opioid Market, by Application, 2020-2034 (USD billion)

Table 9 U.S.: Opioid Market, by Class, 2020-2034 (USD billion)

Table 10 U.S.: Opioid Market, by Product, 2020-2034 (USD billion)

Table 11 U.S.: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 12 U.S.: Opioid Market, by Application, 2020-2034 (USD billion)

Table 13 Canada: Opioid Market, by Class, 2020-2034 (USD billion)

Table 14 Canada: Opioid Market, by Product, 2020-2034 (USD billion)

Table 15 Canada: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 16 Canada: Opioid Market, by Application, 2020-2034 (USD billion)

Table 17 Europe: Opioid Market, by Class, 2020-2034 (USD billion)

Table 18 Europe: Opioid Market, by Product, 2020-2034 (USD billion)

Table 19 Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 20 Europe: Opioid Market, by Application, 2020-2034 (USD billion)

Table 21 UK: Opioid Market, by Class, 2020-2034 (USD billion)

Table 22 UK: Opioid Market, by Product, 2020-2034 (USD billion)

Table 23 UK: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 24 UK: Opioid Market, by Application, 2020-2034 (USD billion)

Table 25 France: Opioid Market, by Class, 2020-2034 (USD billion)

Table 26 France: Opioid Market, by Product, 2020-2034 (USD billion)

Table 27 France: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 28 France: Opioid Market, by Application, 2020-2034 (USD billion)

Table 29 Germany: Opioid Market, by Class, 2020-2034 (USD billion)

Table 30 Germany: Opioid Market, by Product, 2020-2034 (USD billion)

Table 31 Germany: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 32 Germany: Opioid Market, by Application, 2020-2034 (USD billion)

Table 33 Italy: Opioid Market, by Class, 2020-2034 (USD billion)

Table 34 Italy: Opioid Market, by Product, 2020-2034 (USD billion)

Table 35 Italy: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 36 Italy: Opioid Market, by Application, 2020-2034 (USD billion)

Table 37 Spain: Opioid Market, by Class, 2020-2034 (USD billion)

Table 38 Spain: Opioid Market, by Product, 2020-2034 (USD billion)

Table 39 Spain: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 40 Spain: Opioid Market, by Application, 2020-2034 (USD billion)

Table 41 Netherlands: Opioid Market, by Class, 2020-2034 (USD billion)

Table 42 Netherlands: Opioid Market, by Product, 2020-2034 (USD billion)

Table 43 Netherlands: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 44 Netherlands: Opioid Market, by Application, 2020-2034 (USD billion)

Table 45 Russia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 46 Russia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 47 Russia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 48 Russia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 49 Rest of Europe: Opioid Market, by Class, 2020-2034 (USD billion)

Table 50 Rest of Europe: Opioid Market, by Product, 2020-2034 (USD billion)

Table 51 Rest of Europe: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 52 Rest of Europe: Opioid Market, by Application, 2020-2034 (USD billion)

Table 53 Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)

Table 54 Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)

Table 55 Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 56 Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)

Table 57 China: Opioid Market, by Class, 2020-2034 (USD billion)

Table 58 China: Opioid Market, by Product, 2020-2034 (USD billion)

Table 59 China: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 60 China: Opioid Market, by Application, 2020-2034 (USD billion)

Table 61 India: Opioid Market, by Class, 2020-2034 (USD billion)

Table 62 India: Opioid Market, by Product, 2020-2034 (USD billion)

Table 63 India: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 64 India: Opioid Market, by Application, 2020-2034 (USD billion)

Table 65 Malaysia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 66 Malaysia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 67 Malaysia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 68 Malaysia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 69 Japan: Opioid Market, by Class, 2020-2034 (USD billion)

Table 70 Japan: Opioid Market, by Product, 2020-2034 (USD billion)

Table 71 Japan: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 72 Japan: Opioid Market, by Application, 2020-2034 (USD billion)

Table 73 Indonesia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 74 Indonesia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 75 Indonesia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 76 Indonesia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 77 South Korea: Opioid Market, by Class, 2020-2034 (USD billion)

Table 78 South Korea: Opioid Market, by Product, 2020-2034 (USD billion)

Table 79 South Korea: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 80 South Korea: Opioid Market, by Application, 2020-2034 (USD billion)

Table 81 Australia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 82 Australia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 83 Australia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 84 Australia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 85 Rest of Asia Pacific: Opioid Market, by Class, 2020-2034 (USD billion)

Table 86 Rest of Asia Pacific: Opioid Market, by Product, 2020-2034 (USD billion)

Table 87 Rest of Asia Pacific: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 88 Rest of Asia Pacific: Opioid Market, by Application, 2020-2034 (USD billion)

Table 89 Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 90 Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 91 Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 92 Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 93 Saudi Arabia: Opioid Market, by Class, 2020-2034 (USD billion)

Table 94 Saudi Arabia: Opioid Market, by Product, 2020-2034 (USD billion)

Table 95 Saudi Arabia: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 96 Saudi Arabia: Opioid Market, by Application, 2020-2034 (USD billion)

Table 97 UAE: Opioid Market, by Class, 2020-2034 (USD billion)

Table 98 UAE: Opioid Market, by Product, 2020-2034 (USD billion)

Table 99 UAE: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 100 UAE: Opioid Market, by Application, 2020-2034 (USD billion)

Table 101 Israel: Opioid Market, by Class, 2020-2034 (USD billion)

Table 102 Israel: Opioid Market, by Product, 2020-2034 (USD billion)

Table 103 Israel: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 104 Israel: Opioid Market, by Application, 2020-2034 (USD billion)

Table 105 South Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 106 South Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 107 South Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 108 South Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 109 Rest of Middle East & Africa: Opioid Market, by Class, 2020-2034 (USD billion)

Table 110 Rest of Middle East & Africa: Opioid Market, by Product, 2020-2034 (USD billion)

Table 111 Rest of Middle East & Africa: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 112 Rest of Middle East & Africa: Opioid Market, by Application, 2020-2034 (USD billion)

Table 113 Latin America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 114 Latin America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 115 Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 116 Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

Table 117 Mexico: Opioid Market, by Class, 2020-2034 (USD billion)

Table 118 Mexico: Opioid Market, by Product, 2020-2034 (USD billion)

Table 119 Mexico: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 120 Mexico: Opioid Market, by Application, 2020-2034 (USD billion)

Table 121 Brazil: Opioid Market, by Class, 2020-2034 (USD billion)

Table 122 Brazil: Opioid Market, by Product, 2020-2034 (USD billion)

Table 123 Brazil: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 124 Brazil: Opioid Market, by Application, 2020-2034 (USD billion)

Table 125 Argentina: Opioid Market, by Class, 2020-2034 (USD billion)

Table 126 Argentina: Opioid Market, by Product, 2020-2034 (USD billion)

Table 127 Argentina: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 128 Argentina: Opioid Market, by Application, 2020-2034 (USD billion)

Table 129 Rest of Latin America: Opioid Market, by Class, 2020-2034 (USD billion)

Table 130 Rest of Latin America: Opioid Market, by Product, 2020-2034 (USD billion)

Table 131 Rest of Latin America: Opioid Market, by Release Type, 2020-2034 (USD billion)

Table 132 Rest of Latin America: Opioid Market, by Application, 2020-2034 (USD billion)

List of Figures:

Figure 1. Global Opioid Market, 2020-2034 (USD billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Class

Figure 7. Global Opioid Market, by Class, 2024 & 2034 (USD billion)

Figure 8. Market by Product

Figure 9. Global Opioid Market, by Product, 2024 & 2034 (USD billion)

Figure 10. Market by Release Type

Figure 11. Global Opioid Market, by Release Type, 2024 & 2034 (USD billion)

Figure 12. Market by Application

Figure 13. Global Opioid Market, by Application, 2024 & 2034 (USD billion)

Figure 14. Global Opioid Market Assessment, By Geography, 2020-2034 (USD billion)

  • Figure 15. Strategic Analysis - Global Opioid Market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!